PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

SLAS
Bio IT
PEGS Boston
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost

Advertisement

A&M Stabtest April 26
Scientific Lab Show
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
QMB Innovation Centre
Polypure hompage
DDL 2026
Volume 7 Issue 2

Accelerating Drug Discovery for Diseases of Ageing:In Vivo High Throughput Screening with C. elegans

In an era where rapid drug discovery is crucial, high throughput screening (HTS) emerged in the 1990s as a significant development, allowing for the swift and effect...
Continue Reading →
Volume 7 Issue 2

Packaging: The First Line of Defence in Cell and Gene Therapy Logistics

Temperature-controlled packaging plays a vital role in cell and gene therapy logistics. Packaging has a multi-faceted role in supporting cold chain logistics to e...
Continue Reading →
Safeguarding your IP: Thermo Fisher Scientific Pharma Services’ Global Commitment to Confidentiality
Volume 7 Issue 2

Safeguarding your IP: Thermo Fisher Scientific Pharma Services’ Global Commitment to Confidentiality

Intellectual property (IP) rights and confidentiality protections play a critical role in biopharmaceutical development and manufacturing. Appropriate protections en...
Continue Reading →
Understanding Roller Compaction in Pharmaceutical Development
Volume 7 Issue 2

Understanding Roller Compaction in Pharmaceutical Development

David O'Connell of PCI Pharma Services explores the advancements in dry granulation and the fundamentals of roller compaction, presenting it as a viable alternative ...
Continue Reading →
Isosterix Uses CDD Vault to ExpediteDrug Discovery & Securely Collaborate
Volume 7 Issue 2

Isosterix Uses CDD Vault to ExpediteDrug Discovery & Securely Collaborate

SituationRoopa Rai is the Founder and CEO of Isosterix. With over 25 years of experience, Roopa has held leadership positions in discovery research in various therap...
Continue Reading →
Volume 7 Issue 1

Biotech Sector Survey: From Investment Confidence to Strategic Collaborations

In the rapidly evolving landscape, ICON’s recently published biotech sector survey provides a roadmap through the intricacies of investment confidence, funding dynam...
Continue Reading →
Volume 7 Issue 1

Extractables and Leachables for Inhaled Medicines

How risk assessments can improve E&L strategies Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) ar...
Continue Reading →
Volume 7 Issue 1

Using Predictive Compliance Risk Analysis to Avoid FDA Penalties

In the complex landscape of global regulations, particularly within healthcare and pharmaceutical sectors, a robust compliance strategy is essential for maintaining ...
Continue Reading →
Volume 7 Issue 1

Patients Are Waiting: Speeding Time to Treatment in Rare Disease

Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines faster. Rare diseases are no longer rare. Every year, people’s l...
Continue Reading →
Volume 7 Issue 1

Elevating Biomanufacturing Efficiencywith N-1 Perfusion Technology

In the dynamic world of biomanufacturing, the quest for improved efficiency and productivity continues to shape industry advancements. Among these innovations, the e...
Continue Reading →
The Bridge 28.01
Newcells 3 June 2024, 15:12
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Aseptic Tech
PharmExcel